Compare ARK Genomic Revolution ETF (ARKG) vs Krispy Kreme Inc (DNUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Krispy Kreme Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Krispy Kreme Inc trades at $3.41 (market cap $593.06M). The key difference: Krispy Kreme Inc pays a 3.47% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Krispy Kreme Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | DNUT | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $43.57 | $4.70 |
52-Week Low | $23.09 | $2.92 |
Market Cap | — | $593.06M |
Enterprise Value | — | $1.79B |
Dividend Yield | — | 3.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Krispy Kreme (DNUT) trades at $3.44, up 0.58% today, amid bearish technical signals and mixed fundamentals. The stock shows negative profitability with a -33.36% net margin and -58.92% ROE, though revenue remains stable near $1.5B. Recent Q1 2026 earnings missed expectations, but Q3 and Q4 2025 beat forecasts. Analyst sentiment is cautiously optimistic with 50% buy ratings, while technical indicators point to resistance near $4.
Outlook hinges on execution of capital-light expansion and cost controls. Risks include persistent losses and high debt, but potential upside exists if turnaround initiatives boost margins. Investors should weigh analyst optimism against weak cash flow trends and competitive pressures in the consumer staples sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →
